Ligand-dependent Interactions of the Ah Receptor with Coactivators in a Mammalian Two-hybrid Assay

Overview

Journal Toxicol Appl Pharmacol

Specialties Pharmacology
Toxicology

Date 2007 Dec 1

PMID 18048071

Citations 28

Authors

Shu Zhang

Craig Rowlands

Stephen Safe

Affiliations

Soon will be listed here.

Abstract

2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) is a high affinity ligand for the aryl hydrocarbon receptor (AhR). In this study, we investigated structure-dependent differences in activation of the AhR by a series of halogenated aromatic hydrocarbons. TCDD, 1,2,3,7,8-pentachlorodibenzo-p-dioxin (PeCDD), 2,3,7,8-tetrachlorodibenzofuran (TCDF), 2,3,4,7,8-pentachlorodibenzofuran (PeCDF), and 3,3',4,4',5-pentachlorobiphenyl (PCB126) induced CYP1A1-dependent activities in HEK293 human embryonic kidney, Panc1 pancreatic cancer, and Hepa1c1c7 mouse hepatoma cell lines. There was a structure-dependent difference in the efficacy of TCDF and PCB126 in HEK293 and Panc1 cells since induced CYP1A1 mRNA levels were lower than observed for the other congeners. A mammalian two-hybrid assay in cells transfected with GAL4-coactivator and AhR-VP16 chimeras was used to investigate structure-dependent interactions of these chimeras in Panc1, HEK293, and Hepa1c1c7 cells. The reporter construct pGAL4-luc contains five tandem GAL4 response elements linked to the luciferase gene and the GAL4-coactivator chimeras express several coactivators including steroid receptor coactivator 1 (SRC-1), SRC-2 and SRC-3, the mediator coactivator TRAP220, coactivator associated arginine methyl transferase 1 (CARM-1), and peroxisome proliferator-activated receptor gamma coactivator 1 (PGC-1). Results of the mammalian two-hybrid studies clearly demonstrate that activation of pGAL4-luc in cells transfected with VP-AhR and GAL4-coactivator chimeras is dependent on the structure of the HAH congener, cell context, and coactivator, suggesting that the prototypical HAH congeners used in this study exhibit selective AhR modulator activity.

Citing Articles

A dysregulated sebum-microbial metabolite-IL-33 axis initiates skin inflammation in atopic dermatitis.

Qiu Z, Zhu Z, Liu X, Chen B, Yin H, Gu C J Exp Med. 2022; 219(10).

PMID: 35977109 PMC: 9375142. DOI: 10.1084/jem.20212397.

The aryl hydrocarbon receptor: A predominant mediator for the toxicity of emerging dioxin-like compounds.

Zhang W, Xie H, Li Y, Zhou M, Zhou Z, Wang R J Hazard Mater. 2021; 426:128084.

PMID: 34952507 PMC: 9039345. DOI: 10.1016/j.jhazmat.2021.128084.

Decoding Cinnabarinic Acid-Specific Stanniocalcin 2 Induction by Aryl Hydrocarbon Receptor.

Patil N, Tang H, Rus I, Zhang K, Joshi A Mol Pharmacol. 2021; 101(1):45-55.

PMID: 34764210 PMC: 8969126. DOI: 10.1124/molpharm.121.000376.

How the AHR Became Important in Cancer: The Role of Chronically Active AHR in Cancer Aggression.

Wang Z, Snyder M, Kenison J, Yang K, Lara B, Lydell E Int J Mol Sci. 2021; 22(1).

PMID: 33396563 PMC: 7795223. DOI: 10.3390/ijms22010387.

Evolution of Hominin Detoxification: Neanderthal and Modern Human Ah Receptor Respond Similarly to TCDD.

Aarts J, Alink G, Franssen H, Roebroeks W Mol Biol Evol. 2020; 38(4):1292-1305.

PMID: 33230523 PMC: 8042735. DOI: 10.1093/molbev/msaa287.

References

McDougal A, Wormke M, Calvin J, Safe S . Tamoxifen-induced antitumorigenic/antiestrogenic action synergized by a selective aryl hydrocarbon receptor modulator. Cancer Res. 2001; 61(10):3902-7. View

Hankinson O . The aryl hydrocarbon receptor complex. Annu Rev Pharmacol Toxicol. 1995; 35:307-40. DOI: 10.1146/annurev.pa.35.040195.001515. View

van den Berg M, Birnbaum L, Denison M, De Vito M, Farland W, Feeley M . The 2005 World Health Organization reevaluation of human and Mammalian toxic equivalency factors for dioxins and dioxin-like compounds. Toxicol Sci. 2006; 93(2):223-41. PMC: 2290740. DOI: 10.1093/toxsci/kfl055. View

Mueller S, Simon S, Chae K, Metzler M, Korach K . Phytoestrogens and their human metabolites show distinct agonistic and antagonistic properties on estrogen receptor alpha (ERalpha) and ERbeta in human cells. Toxicol Sci. 2004; 80(1):14-25. DOI: 10.1093/toxsci/kfh147. View

Jordan V . Antiestrogens and selective estrogen receptor modulators as multifunctional medicines. 1. Receptor interactions. J Med Chem. 2003; 46(6):883-908. DOI: 10.1021/jm020449y. View

Routledge E, White R, Parker M, Sumpter J . Differential effects of xenoestrogens on coactivator recruitment by estrogen receptor (ER) alpha and ERbeta. J Biol Chem. 2000; 275(46):35986-93. DOI: 10.1074/jbc.M006777200. View

Matthews J, Fertuck K, Celius T, Huang Y, Fong C, Zacharewski T . Ability of structurally diverse natural products and synthetic chemicals to induce gene expression mediated by estrogen receptors from various species. J Steroid Biochem Mol Biol. 2002; 82(2-3):181-94. DOI: 10.1016/s0960-0760(02)00159-0. View

Chen I, McDougal A, Wang F, Safe S . Aryl hydrocarbon receptor-mediated antiestrogenic and antitumorigenic activity of diindolylmethane. Carcinogenesis. 1998; 19(9):1631-9. DOI: 10.1093/carcin/19.9.1631. View

Ko H, Okino S, Ma Q, Whitlock Jr J . Transactivation domains facilitate promoter occupancy for the dioxin-inducible CYP1A1 gene in vivo. Mol Cell Biol. 1997; 17(7):3497-507. PMC: 232203. DOI: 10.1128/MCB.17.7.3497. View

10.

Gonzalez F . The aryl hydrocarbon receptor: studies using the AHR-null mice. Drug Metab Dispos. 1998; 26(12):1194-8. View

11.

Gu Y, Hogenesch J, Bradfield C . The PAS superfamily: sensors of environmental and developmental signals. Annu Rev Pharmacol Toxicol. 2000; 40:519-61. DOI: 10.1146/annurev.pharmtox.40.1.519. View

12.

Ciolino H, Yeh G . Inhibition of aryl hydrocarbon-induced cytochrome P-450 1A1 enzyme activity and CYP1A1 expression by resveratrol. Mol Pharmacol. 1999; 56(4):760-7. View

13.

Poland A, Knutson J . 2,3,7,8-tetrachlorodibenzo-p-dioxin and related halogenated aromatic hydrocarbons: examination of the mechanism of toxicity. Annu Rev Pharmacol Toxicol. 1982; 22:517-54. DOI: 10.1146/annurev.pa.22.040182.002505. View

14.

Katzenellenbogen J, OMalley B, Katzenellenbogen B . Tripartite steroid hormone receptor pharmacology: interaction with multiple effector sites as a basis for the cell- and promoter-specific action of these hormones. Mol Endocrinol. 1996; 10(2):119-31. DOI: 10.1210/mend.10.2.8825552. View

15.

Abnet C, Tanguay R, Heideman W, Peterson R . Transactivation activity of human, zebrafish, and rainbow trout aryl hydrocarbon receptors expressed in COS-7 cells: greater insight into species differences in toxic potency of polychlorinated dibenzo-p-dioxin, dibenzofuran, and biphenyl congeners. Toxicol Appl Pharmacol. 1999; 159(1):41-51. DOI: 10.1006/taap.1999.8719. View

16.

Kumar M, TARPEY R, Perdew G . Differential recruitment of coactivator RIP140 by Ah and estrogen receptors. Absence of a role for LXXLL motifs. J Biol Chem. 1999; 274(32):22155-64. DOI: 10.1074/jbc.274.32.22155. View

17.

Zeiger M, Haag R, Hockel J, Schrenk D, Schmitz H . Inducing effects of dioxin-like polychlorinated biphenyls on CYP1A in the human hepatoblastoma cell line HepG2, the rat hepatoma cell line H4IIE, and rat primary hepatocytes: comparison of relative potencies. Toxicol Sci. 2001; 63(1):65-73. DOI: 10.1093/toxsci/63.1.65. View

18.

Gasiewicz T, Kende A, Rucci G, Whitney B, Willey J . Analysis of structural requirements for Ah receptor antagonist activity: ellipticines, flavones, and related compounds. Biochem Pharmacol. 1996; 52(11):1787-803. DOI: 10.1016/s0006-2952(96)00600-4. View

19.

Poland A, Glover E, Kende A . Stereospecific, high affinity binding of 2,3,7,8-tetrachlorodibenzo-p-dioxin by hepatic cytosol. Evidence that the binding species is receptor for induction of aryl hydrocarbon hydroxylase. J Biol Chem. 1976; 251(16):4936-46. View

20.

Safe S . Comparative toxicology and mechanism of action of polychlorinated dibenzo-p-dioxins and dibenzofurans. Annu Rev Pharmacol Toxicol. 1986; 26:371-99. DOI: 10.1146/annurev.pa.26.040186.002103. View